Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies

NCT01080664 is registered in ClinicalTrials.gov with EMD Serono as lead sponsor.

NCT NCT01080664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01080664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies
Lead sponsor
EMD Serono
Phase
Phase 1
Overall status
Terminated
Start date
December 31, 2006
Completion date
August 31, 2011
Enrollment
124 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

haematological malignancies